The U.S. House will vote today on a bill intended to bring down patient prescription drug costs. Several of the bill’s provisions are important to cancer care, including establishing an annual cap on Medicare enrollees’ out-of-pocket expenses, allowing some Medicare beneficiaries to spread out high-cost prescription cost-sharing over the course of the year, and expanding Medicare eligibility for low-income subsidies.

Some recent and current cancer patients are making changes to their cancer treatment due to the coverage and cost of prescription drugs and surprise medical bills, according to new survey results from the American Cancer Society Cancer Action Network (ACS CAN).

The White House announced today it will nominate Dr. Stephen Hahn, an oncologist and chief medical executive at MD Anderson Cancer Center in Houston, as commissioner of the Food and Drug Administration (FDA).